Teens Are Four Times More Likely to Smoke When Parents Do

MarketInnovation
Jul.21.2022
Top medical experts have warned that teens whose parents or primary caregivers smoke, are four times more likely to take up smoking than than their peers whose parents do not.

UK government campaign titled “Better Health Smoke Free” aims to educate adult smokers about how their habit can influence younger people to take up smoking.

Teens Are Four Times More Likely to Smoke When Parents Do

A new campaign released by the UK government titled “Better Health Smoke Free” aims to educate on how adult smokers can influence younger people to take up the habit. Featuring a number of experts on the topic, the Better Health Smoke Free campaign explains that research has shown that teens whose primary caregiver smoked were more than twice as likely to have tried cigarettes (26% vs 11% ) and four times as likely to be a regular smoker (4.9% vs 1.2%).

 

In a film released last year, the NHS and behavioural health experts discussed the link between smoking parents and the subsequent likelihood of their children to smoke. The speakers included GP Dr Nighat Arif, child psychologist Dr Bettina Hohnen, and smoking cessation experts Professor Nick Hopkinson and Dr Anthony Laverty of Imperial College London, who urged parents to act as positive role models by quitting smoking.

 

Parliamentary Under Secretary of State and Minister for Vaccines and Public Health, Maggie Throup MP, added that now a particularly good time to give up smoking is the new year. “We know that many people make a quit attempt in January, and while there are so many good reasons to stop smoking for yourself, we hope that this new campaign – by highlighting the inter-generational smoking link with parents influencing their children – will be the added motivation many need to ditch the cigarettes for good this year,” she said.

 

“With so much help and support available for parents, carers and anyone looking to quit – including the NHS Quit Smoking app, support on Facebook, daily emails and texts, and an online Personal Quit Plan – you won’t be alone in your New Year’s resolution.”

 

Pregnant women should be offered financial incentives

 

In other news, the Royal College of Physicians (RCP) said that pregnant women who are unable to quit smoking should be offered financial incentives to help them achieve the goal. The RCP said that at any point of contact with the NHS, smokers should be provided with “opt-out smoking cessation services.” Moreover, said the group, bearing in mind that most smokers are often from “lower socio-economic groups”, pregnant women should be given financial incentives to motivate them in achieving the goal.

 

These suggestions were put forward as part of a report compiled by the RCP, addressing what can be done to achieve the government’s “Smoke Free 2030” target. Sadly recent data has indicated that as it stands the goal will not actually be achieved until 2050.

 

“The ability of the UK and other countries to rise to major public health challenges is beyond doubt; the Covid-19 pandemic, by far the biggest new challenge to UK and global health in decades, has attracted a public health and economic response of a scale unique in the modern era,” read the report. “Yet in 2020, when Covid-19 killed around 80,000 UK citizens, tobacco smoking killed 94,000.”

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11